Define the elements of current Good Manufacturing Practices (CGMP) for biomanufacturing and pharmaceutical production.
Explain how CGMP helps regulated companies comply with the law: Part 21 of the Code of Federal Regulations (21 CFR 211).
Understand the importance of current Good Documentation Practices (CGDP) for pharmaceuticals and Part 11 of the Code of Federal Regulations (Electronic Record Keeping).
Recognize the consequences of failing to comply with CGMP.
The mission of the FDA
The quality assurance role
Personnel and organization
Buildings and facilities
Equipment
Control of components, drug product containers, and closures
Production and process controls
Packaging and labeling
Holding and distribution
Laboratory controls
Records and reports
Return and salvaged drug products
Complaints and recalls
Good Documentation Practices (GDP)
Computer systems (Part 11)
Regulatory enforcement
0.4
None
None
No
N/A
Provided by NC BioNetwork
N/A
attendance
N/A
Manufacturing Technicians, Team Leaders and Supervisors, Quality Control Personnel, Quality Assurance Personnel, Maintenance/Engineers
N/A
N/A
Manufacturing Technicians
Team Leaders and Supervisors
Quality Control Personnel
Quality Assurance Personnel
Maintenance/Engineers
SEF-414CL
SEF-79524
Cynthia Lawrence
919-335-1037
[email protected]
To be notified when this course becomes available, please use
Wake Tech's Notify Me service.
Requisites: None
To view information on this course and additional non-degree course offerings, visit the Workforce Continuing Education Catalog